Waller E S, Sharanevych M A, Yakatan G J
J Clin Pharmacol. 1982 Oct;22(10):482-9. doi: 10.1002/j.1552-4604.1982.tb02639.x.
Five normal male volunteers participated in an open crossover study designed to examine the disposition of nafcillin given intravenously with and without probenecid. Each subject received two 500 mg iv doses of sodium nafcillin seven days apart, one dose without probenecid and another dose during oral probenecid administration of 1.0 Gm at bedtime prior to the study day and 1.0 Gm two hours before the nafcillin dose. Blood and urine samples were collected for 10 hours after nafcillin dosing. Assay for nafcillin concentrations was performed via the cup-plate technique with M. luteus. Administration of probenecid significantly increased and prolonged circulating plasma concentrations of nafcillin. Probenecid administration significantly, decreased the per cent of nafcillin recovered in the urine (30% vs. 16.9%). Probenecid pretreatment increased the ana under the plasma drug concentration-time curve (AUC) two-fold and decreased the total body clearance significantly with decreases in both renal and non-renal clearance. K12/k21 and Vc did not significantly change with probenecid. Because probenecid coadministration did not appear to change nafcillin distribution while increasing and prolonging plasma concentrations, probenecid can be recommended to be given concurrently when high nafcillin plasma concentrations are desirable. Changes in plasma concentrations are apparently due to alterations in both renal and non-renal clearances of nafcillin.
五名正常男性志愿者参与了一项开放性交叉研究,该研究旨在考察静脉注射萘夫西林时,加用或不加用丙磺舒的情况下萘夫西林的处置情况。每名受试者相隔七天接受两次500mg静脉注射的萘夫西林钠,一次注射时不加丙磺舒,另一次注射时在研究日之前的睡前口服1.0g丙磺舒,并在注射萘夫西林前两小时口服1.0g丙磺舒。在注射萘夫西林后10小时采集血液和尿液样本。采用与藤黄微球菌相关的杯碟技术测定萘夫西林浓度。丙磺舒的使用显著提高并延长了萘夫西林的循环血浆浓度。丙磺舒的使用显著降低了尿液中回收的萘夫西林百分比(30%对16.9%)。丙磺舒预处理使血浆药物浓度-时间曲线下面积(AUC)增加了两倍,并显著降低了总体清除率,同时肾清除率和非肾清除率均降低。丙磺舒对K12/k21和Vc没有显著影响。由于丙磺舒联合使用似乎不会改变萘夫西林的分布,同时会提高并延长血浆浓度,因此当需要较高的萘夫西林血浆浓度时,建议同时使用丙磺舒。血浆浓度的变化显然是由于萘夫西林的肾清除率和非肾清除率均发生了改变。